108 related articles for article (PubMed ID: 12538354)
1. Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas.
McFarlin DR; Lindstrom MJ; Gould MN
Carcinogenesis; 2003 Jan; 24(1):99-105. PubMed ID: 12538354
[TBL] [Abstract][Full Text] [Related]
2. Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation.
Vandal G; Geiling B; Dankort D
PLoS One; 2014; 9(1):e84745. PubMed ID: 24489653
[TBL] [Abstract][Full Text] [Related]
3. Interactions of the amino acid residue at position 31 of the c-Ha-Ras protein with Raf-1 and RalGDS.
Shirouzu M; Morinaka K; Koyama S; Hu CD; Hori-Tamura N; Okada T; Kariya K; Kataoka T; Kikuchi A; Yokoyama S
J Biol Chem; 1998 Mar; 273(13):7737-42. PubMed ID: 9516482
[TBL] [Abstract][Full Text] [Related]
4. Ras-Raf-Arf signaling critically depends on the Dmp1 transcription factor.
Sreeramaneni R; Chaudhry A; McMahon M; Sherr CJ; Inoue K
Mol Cell Biol; 2005 Jan; 25(1):220-32. PubMed ID: 15601844
[TBL] [Abstract][Full Text] [Related]
5. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland.
Thompson TA; Kim K; Gould MN
Cancer Res; 1998 Nov; 58(22):5097-104. PubMed ID: 9823318
[TBL] [Abstract][Full Text] [Related]
6. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation.
Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K
Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717
[TBL] [Abstract][Full Text] [Related]
7. B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
Köhler M; Ehrenfeld S; Halbach S; Lauinger M; Burk U; Reischmann N; Cheng S; Spohr C; Uhl FM; Köhler N; Ringwald K; Braun S; Peters C; Zeiser R; Reinheckel T; Brummer T
Oncogene; 2019 Feb; 38(8):1324-1339. PubMed ID: 30659267
[TBL] [Abstract][Full Text] [Related]
8. H-Ras/mitogen-activated protein kinase pathway inhibits integrin-mediated adhesion and induces apoptosis in osteoblasts.
Tanaka Y; Nakayamada S; Fujimoto H; Okada Y; Umehara H; Kataoka T; Minami Y
J Biol Chem; 2002 Jun; 277(24):21446-52. PubMed ID: 11934900
[TBL] [Abstract][Full Text] [Related]
9. Role of mitogen-activated protein kinases in the induction of parathyroid hormone-related peptide.
Aklilu F; Gladu J; Goltzman D; Rabbani SA
Cancer Res; 2000 Mar; 60(6):1753-60. PubMed ID: 10749150
[TBL] [Abstract][Full Text] [Related]
10. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways.
Shields JM; Rogers-Graham K; Der CJ
J Biol Chem; 2002 Mar; 277(12):9790-9. PubMed ID: 11773051
[TBL] [Abstract][Full Text] [Related]
11. Rat mammary carcinogenesis induced by in situ expression of constitutive Raf kinase activity is prevented by tethering Raf to the plasma membrane.
McFarlin DR; Gould MN
Carcinogenesis; 2003 Jun; 24(6):1149-53. PubMed ID: 12807745
[TBL] [Abstract][Full Text] [Related]
12. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
13. Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.
Gohlke H; Kiel C; Case DA
J Mol Biol; 2003 Jul; 330(4):891-913. PubMed ID: 12850155
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity.
Light Y; Paterson H; Marais R
Mol Cell Biol; 2002 Jul; 22(14):4984-96. PubMed ID: 12077328
[TBL] [Abstract][Full Text] [Related]
15. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
16. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
[TBL] [Abstract][Full Text] [Related]
17. COMBINE analysis of the specificity of binding of Ras proteins to their effectors.
Tomić S; Bertosa B; Wang T; Wade RC
Proteins; 2007 May; 67(2):435-47. PubMed ID: 17295314
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of gene induction and cell growth by the Ras effector Rlf.
Wolthuis RM; de Ruiter ND; Cool RH; Bos JL
EMBO J; 1997 Nov; 16(22):6748-61. PubMed ID: 9362489
[TBL] [Abstract][Full Text] [Related]
19. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells.
Kato-Stankiewicz J; Hakimi I; Zhi G; Zhang J; Serebriiskii I; Guo L; Edamatsu H; Koide H; Menon S; Eckl R; Sakamuri S; Lu Y; Chen QZ; Agarwal S; Baumbach WR; Golemis EA; Tamanoi F; Khazak V
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14398-403. PubMed ID: 12391290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
